Objectives: To identify the most likely mechanisms of retinal ischemia and
embolism in a hospital-referred population, and to determine the frequency
of recurrent vascular events during the 3-month period following initial pr
esentation. Methods. Consecutive patients presenting to 2 tertiary medical
centers and their outpatient clinics were prospectively enrolled over a 22-
month period. Eligible patients presented with histories of transient or pe
rmanent monocular visual loss, or had evidence of asymptomatic retinal embo
lism on routine ophthalmological examination. They underwent a rapid and st
andardized evaluation that included imaging studies as well as blood tests,
and follow-up was obtained at 1 and 3 months. Results: Seventy-seven patie
nts were enrolled. Enrollment diagnoses consisted of amaurosis fugax (n = 3
2), asymptomatic retinal embolism (n = 34), and central or branch retinal a
rtery occlusion (n = 11). Eight different presumed etiologies of retinal ar
tery distribution embolism or hypoperfusion were identified. Extracranial i
nternal carotid artery occlusion or more than 50% stenosis was observed in
17/77 (22.1%) cases, making it the largest etiologic subgroup. Uncommon but
treatable conditions were identified in 8/77 (10.4%) patients, and an etio
logic diagnosis could not be made in 35/77 (45.5%) patients. Recurrent even
ts occurred in, respectively, 14/77 (18.2%) and 6/73 (8.2%) patients at the
1- and 3-month follow-ups. They included 2 infarcts and 2 deaths; ischemic
events of the retina were more common than those involving the brain. Conc
lusion: Severe stenosis of the extracranial internal carotid artery is the
most common identified condition associated with retinal ischemia and embol
ism, but a variety of other, potentially treatable, conditions can be diagn
osed if appropriate and specific evaluations are conducted. The frequency o
f recurrent vascular ischemic events is highest during the 1st month of fol
low-up and decreases during the 2nd and 3rd months. Recurrences range from
relatively innocuous episodes of amaurosis fugax to vascular death. Copyrig
ht (C) 2001 S. Karger AG, Basel.